TrialActa oncologica (Stockholm, Sweden)2024

Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study.

Ivar Hompland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.